Registration 333-295063
Underwriters: Maxim Group LLC
Company research
ROKIT America, Inc.
CIK 2087716Updated Oct 6, 2026
Filing activity
Latest filing
4 filings on record · S-1/A, S-1, DRS/A.
About the company
ROKIT Healthcare currently plans human clinical evaluations for its cartilage regeneration platform primarily in South Korea and Egypt. Based on the clinical evaluation data generated from these evaluations, the Company is exploring regulatory pathways to expand its market presence into the United States and other global jurisdictions.
Recent filings
Offerings
Filing attachments
rokit_ex42.htm · S-1/A · 2026-06-04
EX-4.2 3 rokit_ex42.htm FORM OF REPRESENTATIVE'S WARRANT. rokit_ex42.htm EXHIBIT 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER…
Read attachment ↗rokit_ex107.htm · S-1 · 2026-04-15
EXHIBIT 107 Calculation of Filing Fee Tables Form S-1 (Form Type) ROKIT America, Inc. (Exact Name of Registrant as Specified in its Charter) Not Applicable (Translation of Registrant’s Name into English) Table 1: Newly Registered Securities Security Security Fee Amount Proposed Maximum Fee Rate Amount of …
Read attachment ↗